RPGLIFE — RPG Life Sciences Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹37.92bn
- IN₹35.17bn
- IN₹7.08bn
Annual cashflow statement for RPG Life Sciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 732 | 917 | 1,178 | 2,329 | 1,542 |
| Depreciation | |||||
| Non-Cash Items | -21.2 | -21.9 | -41.5 | -977 | -388 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -220 | -142 | -364 | -788 | -804 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 648 | 908 | 944 | 779 | 565 |
| Capital Expenditures | -240 | -327 | -692 | -360 | -654 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -107 | -731 | -99.2 | -57.7 | 1,512 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -347 | -1,058 | -792 | -418 | 858 |
| Financing Cash Flow Items | -5.2 | -3.1 | -4.5 | -6.2 | -8.9 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -135 | -171 | -203 | -271 | -206 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 166 | -321 | -51 | 89.8 | 1,218 |